INHIBITION OF 5-FLUOROURACIL-INDUCED OCULAR IRRITATION BY OCULAR ICE PACKS

被引:0
|
作者
LOPRINZI, CL
WENDER, DB
VEEDER, MH
OFALLON, JR
VAUGHT, NL
DOSE, AM
GHOSH, C
BARTEL, J
LEITCH, JM
机构
[1] SIOUXLAND HEMATOL ONCOL ASSOCIATES,SIOUX CITY,IA
[2] ILLINOIS ONCOL RES ASSOC,COMMUNITY CLIN ONCOL PROGRAM,PEORIA,IL
[3] MAYO CLIN & MAYO FDN,CANC STAT UNIT,ROCHESTER,MN 55905
[4] CEDAR RAPIDS ONCOL PROJECT,CEDAR RAPIDS,IA
[5] SASKATCHEWAN CANC FDN,ALLAN BLAIR MEM CLIN,REGINA,SK,CANADA
[6] ST LUKES HOSP,CCOP,FARGO,ND
关键词
5-FLUOROURACIL-INDUCED OCULAR TOXICITY; 5-FLUOROURACIL-INDUCED CONJUNCTIVITIS; OCULAR ICE PACKS;
D O I
10.1002/1097-0142(19940801)74:3<945::AID-CNCR2820740324>3.0.CO;2-C
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. This clinical trial was developed to determine whether ocular ice pack therapy would decrease 5-fluorouracil (5-FU)-induced ocular toxicity. Methods. Sixty-two patients who suffered from 5-FU-induced ocular toxicity, and were scheduled to receive another cycle of the chemotherapy that caused the ocular toxicity, were entered in this clinical trial. A randomized, crossover design was used, with patients documenting their ocular toxicity by the use of daily diaries. Results. The results from the first cycle of treatment suggested that ocular ice pack therapy decreased 5-FU-induced ocular toxicity (P = 0.056). The 38 evaluable patients in the crossover analyses demonstrated decreased ocular toxicity with ocular ice pack therapy (p=.001). The ocular ice pack therapy was well tolerated by most of the study participants. Conclusion. Ocular ice pack therapy appears to lessen 5-FU-induced ocular toxicity to a clinically moderate degree. Better methods for decreasing 5-FU-induced ocular toxicity are necessary.
引用
收藏
页码:945 / 948
页数:4
相关论文
共 50 条
  • [41] Genetic Polymorphisms Associated with 5-Fluorouracil-Induced Neurotoxicity
    Kim, Suk-Ran
    Park, Chang-Hun
    Park, Silvia
    Park, Joon-Oh
    Lee, Jeeyun
    Lee, Soo-Youn
    CHEMOTHERAPY, 2010, 56 (04) : 313 - 317
  • [42] OCULAR SIDE-EFFECTS WITH 5-FLUOROURACIL
    CHRISTOPHIDIS, N
    VAJDA, FJE
    LUCAS, I
    LOUIS, WJ
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1979, 9 (02): : 143 - 144
  • [43] 5-FLUOROURACIL TOXICITY TO THE OCULAR SURFACE EPITHELIUM
    SHAPIRO, MS
    THOFT, RA
    FRIEND, J
    PARRISH, RK
    GRESSEL, MG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1985, 26 (04) : 580 - 583
  • [44] SUBCONJUNCTIVAL 5-FLUOROURACIL MECHANISMS OF OCULAR PENETRATION
    FANTES, FE
    PARRISH, RK
    HEUER, DK
    SOSSI, N
    OPHTHALMIC SURGERY AND LASERS, 1987, 18 (05): : 375 - 378
  • [45] Ocular surface, ocular adnexal, and lacrimal complications associated with the use of systemic 5-fluorouracil
    Eiseman, AS
    Flanagan, JC
    Brooks, AB
    Mitchell, EP
    Pemberton, CH
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 19 (03): : 216 - 224
  • [46] The confused cancer patient: a case of 5-fluorouracil-induced encephalopathy
    Cheung, W. Y.
    Fralick, R. A.
    Cheng, S.
    CURRENT ONCOLOGY, 2008, 15 (05) : 234 - 236
  • [47] EVALUATION OF 5-FLUOROURACIL-INDUCED CARDIOTOXICITY: ROLE OF CARDIAC BIOMARKERS
    Moghaddam, Zhaleh Karimi
    Rostami, Mina
    Zeraatchi, Alireza
    Abadi, Hamidreza Fallah
    Karamitanha, Farzaneh
    Amirmoghaddami, Hamidreza
    EXPERIMENTAL ONCOLOGY, 2022, 44 (01) : 60 - 66
  • [48] 5-Fluorouracil-induced hyperammonaemic encephalopathy: A French national survey
    Boileve, Alice
    Thomas, Laure
    Lillo-Le Louet, Agnes
    Gaboriau, Louise
    Chouchana, Laurent
    Ducreux, Michel
    Malka, David
    Boige, Valerie
    Hollebecque, Antoine
    Hillaire-Buys, Dominique
    Jozwiak, Mathieu
    EUROPEAN JOURNAL OF CANCER, 2020, 129 : 32 - 40
  • [49] Saroglitazar ameliorates 5-Fluorouracil-induced hepatorenal damage in rats
    Alharbi, Alhomedy M.
    Kafl, Hoda E.
    Abdelaziz, Rania R.
    Suddek, Ghada M.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [50] CARDIAC ARREST FROM 5-FLUOROURACIL-INDUCED VENTRICULAR FIBRILLATION
    Saad, Eltaib
    Abdulrahman, Ahmed
    Friedman, Harvey J.
    CHEST, 2023, 164 (04) : 537A - 537A